Chu Yu-Waye

CIK 00018545862 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001854586

Recent Transactions

33 trades

Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-09-26+87,500→ 87,500 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2025-09-26+43,750→ 43,750 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-03-18$0.60/sh−4,025→ 135,725 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-02-04+238,000→ 238,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-02-04+56,000→ 82,250 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2025-02-04+115,000→ 115,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2025-02-04+57,500→ 139,750 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2024-01-18+75,000→ 75,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2024-01-18+122,500→ 122,500 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2024-01-18+26,250→ 26,250 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2023-07-19+375,000→ 375,000 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2023-04-18$6.52/sh−215→ 142,993 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2023-04-18$6.58/sh−2,317→ 140,676 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2023-02-06+425,000→ 425,000 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2023-01-10$5.24/sh−7,825→ 143,208 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-04-19$35.37/sh−4,062→ 151,033 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2022-01-25+53,058→ 53,058 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2022-01-25+33,302→ 155,095 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-01-11$48.44/sh−3,547→ 122,211 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-01-11$49.10/sh−418→ 121,793 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-10$49.32/sh−2,097→ 131,161 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-10$53.66/sh−1,031→ 126,363 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-10$52.37/sh−1,822→ 127,394 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-10$50.42/sh−900→ 130,261 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-10$16.32/sh+7,500→ 133,258 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-10$51.08/sh−1,045→ 129,216 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-10$55.54/sh−5→ 125,758 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2021-12-10$54.58/sh−600→ 126,763 total
Exercise/Conversion
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2021-12-10−7,500→ 105,000 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2021-11-19+60,958→ 125,758 total
Sale
FATE THERAPEUTICS INC$FATE
Common stock
2021-04-16$81.80/sh−875→ 67,200 total
Sale
FATE THERAPEUTICS INC$FATE
Common stock
2021-04-16$84.41/sh−1,500→ 64,800 total
Sale
FATE THERAPEUTICS INC$FATE
Common stock
2021-04-16$82.91/sh−900→ 66,300 total

Companies

Recent Filings

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov